The FDA submitted a proposal to the International Council for Harmonisation (ICH) recommending the development of internationally harmonized guidelines on scientific and technical standards for generic drugs. The FDA specifically asked ICH to develop a series of guidelines on standards for demonstrating equivalence for both noncomplex dosage forms and for more complex dosage forms and drug products.